Liver and/or lung metastasectomy after cetuximab or bevacizumab+FOLFIRI chemotherapy in patients (pts) with metastatic colorectal cancer (mCRC). This is an ASCO Meeting Abstract from the . This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback